Primary sclerosing cholangitis screening: Difference between revisions
Jump to navigation
Jump to search
Created page with "{{Primary sclerosing cholangitis}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Gastroenterology}} Category:Autoimmune diseases Category:Gastroenterology [[Ca..." |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Primary sclerosing cholangitis}} | {{Primary sclerosing cholangitis}}{{CMG}} | ||
{{CMG}} | |||
==Overview== | ==Overview== | ||
PSC is associated with [[cholangiocarcinoma]], which are tumors involving the biliary tree. Screening for cholangiocarcinoma in patients with PSC is encouraged, but there is no general consensus on the modality and interval of choice. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Revision as of 22:12, 7 February 2012
|
Primary sclerosing cholangitis Microchapters |
|
Differentiating Primary sclerosing cholangitis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Primary sclerosing cholangitis screening On the Web |
|
American Roentgen Ray Society Images of Primary sclerosing cholangitis screening |
|
Directions to Hospitals Treating Primary sclerosing cholangitis |
|
Risk calculators and risk factors for Primary sclerosing cholangitis screening |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
PSC is associated with cholangiocarcinoma, which are tumors involving the biliary tree. Screening for cholangiocarcinoma in patients with PSC is encouraged, but there is no general consensus on the modality and interval of choice.